SHMLF (SHL Telemedicine) Receivables Turnover: 3.85 (As of Dec. 2025)


SHMLF SHL Telemedicine Ltd SHMLF
52 GF Score
Price $4.84
GF Value $12.09
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine Receivables Turnover?

SHL Telemedicine SHMLF 52 Receivables Turnover is 3.85 as of Dec. 2025. GuruFocus rates SHMLF with a GF Score™ of 52/100 and a GF Value™ of $12.09. The stock has 3 warning signs investors should review. Among 656 Healthcare Providers & Services companies, SHL Telemedicine ranks worse than 53.05% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. SHL Telemedicine's Revenue for the six months ended in Dec. 2025 was $30.78 Mil. SHL Telemedicine's average Accounts Receivable for the six months ended in Dec. 2025 was $7.99 Mil. Hence, SHL Telemedicine's Receivables Turnover for the six months ended in Dec. 2025 was 3.85.


SHL Telemedicine  (OTCPK:SHMLF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


SHL Telemedicine Receivables Turnover Related Terms


SHL Telemedicine Receivables Turnover Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Receivables Turnover Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.60 7.41 6.98 7.16 7.36

SHL Telemedicine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 3.41 3.83 3.81 3.85

SHMLF vs VEEV, BTSG, TEM: Receivables Turnover Comparison

For the Health Information Services subindustry, SHL Telemedicine's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Receivables Turnover falls into.


SHMLF
52GF Score
SHL Telemedicine Ltd SHMLF
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

SHL Telemedicine's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=58.694 / ((7.309 + 8.65) / 2 )
=58.694 / 7.9795
=7.36

SHL Telemedicine's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=30.775 / ((7.337 + 8.65) / 2 )
=30.775 / 7.9935
=3.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 3.85 mean?
SHL Telemedicine (SHMLF) has a Receivables Turnover of 3.85 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SHL Telemedicine and its competitors. According to the industry distribution chart, SHL Telemedicine ranks #348 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 53%.
Is SHL Telemedicine's Receivables Turnover too high?
SHL Telemedicine's current Receivables Turnover is 3.85. The Healthcare Providers & Services industry median Receivables Turnover is 7.69. SHL Telemedicine's value of 3.85 is 49.9% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #348 out of 656 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #348 out of 656 companies for Receivables Turnover. This places SHL Telemedicine in the lower half of its industry. The industry median Receivables Turnover is 7.69. SHL Telemedicine's value of 3.85 is 49.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.69, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Receivables Turnover of 3.85 is 49.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Receivables Turnover is 3.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Receivables Turnover of 3.85. The stock's GF Value™ is $12.09, compared to a current price of $4.84 — trading 59.9% below its estimated fair value. The current Receivables Turnover is 3.85 and 49.9% below the Healthcare Providers & Services industry median of 7.69. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Receivables Turnover is 3.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (SHMLF) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of $4.84 is trading 59.9% below its estimated GF Value™ of $12.09.

Key valuation signals for SHMLF:

  • Receivables Turnover: 3.85
  • GF Value™: $12.09 vs. price of $4.84 (59.9% below fair value)
  • GF Score™: 52/100 with 3 warning signs
  • Industry Position: 49.9% below the Healthcare Providers & Services median (#348 of 656)

No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SHL Telemedicine Business Description

Other Exchanges 0QMX:UKSHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score

Get the complete analysis for SHMLF

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price
$12.09
GF Value